Ionis Pharmaceuticals (IONS)
Healthcare · Biotechnology
2 members of Congress have disclosed 2 trades in Ionis Pharmaceuticals (IONS) since 2016: 0 buys and 2 sales. The most recent was disclosed on Apr 17, 2023.
- Trades disclosed
- 2
- Members trading
- 2
- Buys / sells
- 0 / 2
- Reported value
- $2K–$30K
Keep following the company.
Subscribers get new congressional filings and notable insider purchases for companies they follow. Coverage varies by company.
What else is happening at IONS
All research →Company filings and public records connected to this stock, ordered by when they became public or were first observed.
No matching research items have been collected yet. Coverage is growing; an empty result does not mean there has been no activity.
Who traded IONS
- Rep. Daniel S. Goldman (D-NY-10)0 buys · 1 sale01Apr 17, 2023
- Sen. Sheldon Whitehouse (D-RI)0 buys · 1 sale01Feb 23, 2016
All trades
- Apr 17, 2023$1K–$15K
Rep. Daniel S. Goldman (D-NY-10)
Sold Ionis Pharmaceuticals IONS
$1K–$15K · Traded Mar 6, 2023 · disclosed Apr 17, 2023
- Feb 23, 2016$1K–$15K
Sen. Sheldon Whitehouse (D-RI)
Sold (full) Ionis Pharmaceuticals IONS
$1K–$15K · Traded Jan 20, 2016 · disclosed Feb 23, 2016
From periodic transaction reports filed under the STOCK Act. Amounts are the ranges members report, and trades can be disclosed up to 45 days after they happen. Nothing here is investment advice.